<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">
<DIV style="font-size: 10pt">
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>

<P style="font-size: 14pt" align="center"><B>UNITED STATES<BR>
SECURITIES AND
EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P style="font-size: 18pt" align="center"><B>FORM 8-K</B>

<P style="font-size: 12pt" align="center"><B>CURRENT REPORT<BR>
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P style="font-size: 10pt" align="center"><B>Date of Report (Date of earliest
event reported): February 19, 2008 (February 18, 2008)</B>

<P style="font-size: 24pt" align="center"><B>KREIDO BIOFUELS,
INC.<BR>
</B><FONT style="font-size: 10pt">(Exact name of registrant as
specified in its charter) </FONT>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="32%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="33%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="32%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>Nevada</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>333-130606</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>20-3240178</B></TD>
 </TR>
 <TR valign="top">
  <TD>(State or other Jurisdiction of Incorporation)</TD>
  <TD>&nbsp;</TD>
  <TD>(Commission File Number)</TD>
  <TD>&nbsp;</TD>
  <TD>(IRS Employer Identification No.)</TD>
 </TR>

</TABLE>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="49%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="49%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>1070 Flynn
Road<BR>
Camarillo, California<BR>
</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>93012</B></TD>
 </TR>
 <TR valign="top">
  <TD>(Address of Principal Executive Offices)</TD>
  <TD>&nbsp;</TD>
  <TD>(Zip Code)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">Registrant&#8217;s telephone number,
including area code: <B>(805) 389-3499</B>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="30%" border="0">

 <TR>
  <TD width="100%">&nbsp;</TD>
 </TR>
 <TR>
  <TD style="border-bottom: #000000 1px solid" nowrap><B>Not
applicable<BR>
</B></TD>
 </TR>
 <TR>
  <TD nowrap>(Former name or former address if changed since last report.)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:

<P style="font-size: 10pt" align="left"><FONT face="Wingdings">o</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<P>&nbsp;
<DIV
style="margin-top: 10pt; font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="left"><B>Item&nbsp;8.01 Other Events.</B>

<P style="font-size: 10pt; text-indent: 4%" align="left">On February&nbsp;18,
2009, Kreido Biofuels, Inc. (the &#8220;Company&#8221;) deposited in the mail
to its stockholders of record Notice of an Annual Meeting of Stockholders to be
held on March&nbsp;4, 2009 for the following purposes: (1)&nbsp;to consider and
vote on a proposal to approve the Asset Purchase Agreement dated as of
January&nbsp;28, 2009 among Four Rivers BioEnergy, Inc., a Nevada corporation,
The Four Rivers BioEnergy Company, Inc., a Kentucky corporation, Kreido
Laboratories, a California corporation, and Kreido Biofuels, Inc. and the
transactions therein; (2)&nbsp;to elect four directors; (3)&nbsp;to consider
and vote to adjourn the meeting, if necessary, to solicit additional proxies if
there are insufficient votes at the meeting to approve the Asset Purchase
Agreement, and (4)&nbsp;to transact such other business as may properly come
before the meeting and any and all adjourned sessions thereof.

<P style="font-size: 10pt; text-indent: 4%" align="left">The Company is
furnishing the information in this Current Report on Form 8-K and in Exhibits
99.1 and 99.2 to comply with Regulation&nbsp;FD. Such information shall not be
deemed to be &#8220;filed&#8221; for purposes of Section&nbsp;18 of the
Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act&#8221;),
or otherwise subject to the liabilities of that section, and shall not be
deemed to be incorporated by reference into any of the Company&#8217;s filings
under the Securities Act of 1933, as amended, or the Exchange Act whether made
before or after the date hereof and regardless of any general incorporation
language in such filings, except to the extent expressly set forth by specific
reference in such a filing.

<P style="font-size: 10pt" align="left"><B>Item&nbsp;9.01 Financial Statements
and Exhibits.</B> <BR>
&nbsp;
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="3%">&nbsp;</TD>
  <TD width="4%">&nbsp;</TD>
  <TD width="93%">&nbsp;</TD>
 </TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
 <TR valign="bottom">
  <TD valign="top"><DIV style="margin-left: 0px; text-indent: 0px">(d) </DIV></TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Exhibits (furnished solely for purposes of
Item&nbsp;8.01 of this Form&nbsp;8-K)</TD>
 </TR>
<!-- End Table Body -->

</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="8%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="87%">&nbsp;</TD>
 </TR>
<!-- End Table Head -->

<!-- Begin Table Body -->

 <TR valign="bottom">
  <TD style="border-bottom: 1px solid #000000" valign="top" align="left">Exhibit Number</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
</TR>

<TR><TD>&nbsp;</TD></TR>

 <TR valign="bottom">
  <TD valign="top">99.1</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Letter to Stockholders, Notice of Annual
Meeting , Proxy Statement and form of Proxy dated February&nbsp;18, 2009</TD>
 </TR>

<TR><TD>&nbsp;</TD></TR>

 <TR valign="bottom">
  <TD valign="top">99.2</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Asset Purchase Agreement dated as of January&nbsp;28, 2009 by and among Four Rivers
BioEnergy, Inc., The Four Rivers BioEnergy Company, Inc., Kreido Biofuels, Inc.
and Kreido Laboratories</TD>
 </TR>

<!-- End Table Body -->

</TABLE>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center">&nbsp;<U><B>Safe Harbor Statement
under the Private Securities Litigation Reform Act of 1995</B></U>

<P style="font-size: 10pt" align="left">Information included in this Form 8-K
may contain forward-looking statements within the meaning of Section&nbsp;27A
of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)
and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the
&#8220;Exchange Act&#8221;). This information may involve known and unknown
risks, uncertainties and other factors which may cause the Company&#8217;s
actual results, performance or achievements to be materially different from
future results, performance or achievements expressed or implied by any
forward-looking statements. Forward-looking statements, which involve
assumptions and describe the Company&#8217;s future plans, strategies and
expectations, are generally identifiable by use of the words &#8220;may,&#8221;
&#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221;
&#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;believe,&#8221;
&#8220;intend&#8221; or &#8220;project&#8221; or the negative of these words or
other variations on these words or comparable terminology. These
forward-looking statements are based on assumptions that may be incorrect, and
there can be no assurance that any projections included in these
forward-looking statements will come to pass. The Company&#8217;s actual
results could differ materially from those expressed or implied by the
forward-looking statements as a result of various factors. Except as required
by applicable laws, the Company undertakes no obligation to update publicly any
forward-looking statements for any reason, even if new information becomes
available or other events occur in the future.

<P style="font-size: 10pt" align="center">&nbsp;

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center"><B>SIGNATURES</B>

<P style="font-size: 10pt; text-indent: 4%" align="left">Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="48%">&nbsp;</TD>
  <TD width="6%">&nbsp;</TD>
  <TD width="46%">&nbsp;</TD>
 </TR>
 <TR style="font-size: 10pt" valign="bottom">
  <TD nowrap align="left">Dated: February 19, 2009</TD>
  <TD align="left" colspan="2"><B>KREIDO BIOFUELS, INC.</B></TD>
 </TR>

<!-- End Table Head -->

<!-- Begin Table Body -->

<TR><TD>&nbsp;</TD></TR>

 <TR valign="bottom">
  <TD valign="top">&nbsp;</TD>
  <TD align="left">By: &nbsp;</TD>
  <TD valign="top" align="left" style="border-bottom: #000000 1px solid">/s/ G.A. Ben Binninger</TD>
 </TR>

 <TR valign="bottom">
  <TD valign="top">&nbsp;</TD>
  <TD align="left">Name:</TD>
  <TD valign="top" align="left">G.A. Ben Binninger </TD>
 </TR>

 <TR valign="bottom">
  <TD valign="top">&nbsp;</TD>
  <TD align="left">Its: </TD>
  <TD align="left">Chief Executive Officer</TD>
 </TR>
<!-- End Table Body -->

</TABLE>
</DIV>



<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">4
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center"><B>EXHIBIT INDEX</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="8%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="87%">&nbsp;</TD>
 </TR>
<!-- End Table Head -->

<!-- Begin Table Body -->

 <TR valign="bottom">
  <TD style="border-bottom: 1px solid #000000" valign="top" align="left"><B>Exhibit<BR>Number</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: 1px solid #000000" valign="bottom" align="left"><B>Description</B></TD>
</TR>

<TR><TD>&nbsp;</TD></TR>

 <TR valign="bottom">
  <TD valign="top">99.1</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Letter to Stockholders, Notice of Annual
Meeting , Proxy Statement and form of Proxy dated February&nbsp;18, 2009</TD>
 </TR>

<TR><TD>&nbsp;</TD></TR>

 <TR valign="bottom">
  <TD valign="top">99.2</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Asset Purchase Agreement dated as of January&nbsp;28, 2009 by and among Four Rivers
BioEnergy, Inc., The Four Rivers BioEnergy Company, Inc., Kreido Biofuels, Inc.
and Kreido Laboratories</TD>
 </TR>

<!-- End Table Body -->

</TABLE>
</DIV>





</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c81439e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 13252}]
{"company-data": {"conformed-name": "Kreido Biofuels, Inc.", "cik": "0001342219", "assigned-sic": "2860", "irs-number": "203240178", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-130606", "film-number": "09626293"}, "business-address": {"street1": "1140 AVENIDA ACASO", "city": "CAMARILLO", "state": "CA", "zip": "93012", "phone": "805-389-3499"}, "mail-address": {"street1": "1140 AVENIDA ACASO", "city": "CAMARILLO", "state": "CA", "zip": "93012"}, "former-company": {"former-conformed-name": "Gemwood Productions, Inc.", "date-changed": "20051024"}}
Filed by Bowne Pure Compliance
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): February 19, 2008 (February 18, 2008)
KREIDO BIOFUELS,
INC.
(Exact name of registrant as
specified in its charter)
Nevada
333-130606
20-3240178
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
1070 Flynn
Road
Camarillo, California
93012
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number,
including area code:
(805) 389-3499
Not
applicable
(Former name or former address if changed since last report.)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On February 18,
2009, Kreido Biofuels, Inc. (the "Company") deposited in the mail
to its stockholders of record Notice of an Annual Meeting of Stockholders to be
held on March 4, 2009 for the following purposes: (1) to consider and
vote on a proposal to approve the Asset Purchase Agreement dated as of
January 28, 2009 among Four Rivers BioEnergy, Inc., a Nevada corporation,
The Four Rivers BioEnergy Company, Inc., a Kentucky corporation, Kreido
Laboratories, a California corporation, and Kreido Biofuels, Inc. and the
transactions therein; (2) to elect four directors; (3) to consider
and vote to adjourn the meeting, if necessary, to solicit additional proxies if
there are insufficient votes at the meeting to approve the Asset Purchase
Agreement, and (4) to transact such other business as may properly come
before the meeting and any and all adjourned sessions thereof.
The Company is
furnishing the information in this Current Report on Form 8-K and in Exhibits
99.1 and 99.2 to comply with Regulation FD. Such information shall not be
deemed to be "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, (the "Exchange Act"),
or otherwise subject to the liabilities of that section, and shall not be
deemed to be incorporated by reference into any of the Company's filings
under the Securities Act of 1933, as amended, or the Exchange Act whether made
before or after the date hereof and regardless of any general incorporation
language in such filings, except to the extent expressly set forth by specific
reference in such a filing.
Item 9.01 Financial Statements
and Exhibits.
(d)
Exhibits (furnished solely for purposes of
Item 8.01 of this Form 8-K)
Exhibit Number
99.1
Letter to Stockholders, Notice of Annual
Meeting , Proxy Statement and form of Proxy dated February 18, 2009
99.2
Asset Purchase Agreement dated as of January 28, 2009 by and among Four Rivers
BioEnergy, Inc., The Four Rivers BioEnergy Company, Inc., Kreido Biofuels, Inc.
and Kreido Laboratories
Safe Harbor Statement
under the Private Securities Litigation Reform Act of 1995
Information included in this Form 8-K
may contain forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933, as amended (the "Securities Act")
and Section 21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"). This information may involve known and unknown
risks, uncertainties and other factors which may cause the Company's
actual results, performance or achievements to be materially different from
future results, performance or achievements expressed or implied by any
forward-looking statements. Forward-looking statements, which involve
assumptions and describe the Company's future plans, strategies and
expectations, are generally identifiable by use of the words "may,"
"will," "should," "expect,"
"anticipate," "estimate," "believe,"
"intend" or "project" or the negative of these words or
other variations on these words or comparable terminology. These
forward-looking statements are based on assumptions that may be incorrect, and
there can be no assurance that any projections included in these
forward-looking statements will come to pass. The Company's actual
results could differ materially from those expressed or implied by the
forward-looking statements as a result of various factors. Except as required
by applicable laws, the Company undertakes no obligation to update publicly any
forward-looking statements for any reason, even if new information becomes
available or other events occur in the future.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
Dated: February 19, 2009
KREIDO BIOFUELS, INC.
By:
/s/ G.A. Ben Binninger
Name:
G.A. Ben Binninger
Its:
Chief Executive Officer
EXHIBIT INDEX
Exhibit
Number
Description
99.1
Letter to Stockholders, Notice of Annual
Meeting , Proxy Statement and form of Proxy dated February 18, 2009
99.2
Asset Purchase Agreement dated as of January 28, 2009 by and among Four Rivers
BioEnergy, Inc., The Four Rivers BioEnergy Company, Inc., Kreido Biofuels, Inc.
and Kreido Laboratories